MDCX
MDCX
NASDAQ · Biotechnology

Medicus Pharma Ltd

$1.11
+0.02 (+1.83%)
As of Feb 8, 2:23 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +570.3% upside
Low Target $4.65
Average Target $7.44
High Target $8.88
Current Price $1.11
Current
$1.11
Target
$7.44
$4.65 $7.44 avg $8.88
Scenario Analysis
Bear Case
$4.65
318.9%
Low target
Base Case
$7.44
+570.3%
Avg target
Bull Case
$8.88
+700.0%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$8.35
-86.7% from high
52-Week Low
$4.52
+-75.4% from low
Target vs 52W High
$7.44
-10.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%